Saturday, 16 November 2013
Contact Us
Search
Home
About us
Corporate Overview
History
Management Team
Advisory Boards
Partnering & Licensing
Contact
Contact Us
Impressum
News
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Chemogenomics
Product Portfolio
Pipeline Summary
RP101
RP101 Inhibition
Hsp27
Key Effects
Interaction
Hsp27 Suppression
Pancreatic Cancer
The Role of Hsp27
Clinical Effects of RP101
Summary of Clinical Trials
Competitive Advantage
2nd Generation
Navigation
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Subscribe our Newsletter
Name
E-mail
Subscribe
Unsubscribe
Home
News
Newsletter
Newsletter Item
[ back ]
Date: 2009-02-13 17:13:24
Los Angeles Award 2008
Los Angeles Award 2008
On 6 November 2008, the RP101 program was awarded the 2008 Los Angeles Award in the Medical Research category.
Powered by
Letterman
